Engage

product on market Capsule Centurion Labz Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains antioxidants and hepatoprotective agents like Milk Thistle and N-Acetyl-L-Cysteine, which have moderate evidence for supporting liver health. Grape seed and cranberry extracts provide polyphenols with limited evidence for systemic antioxidant support. Overall, these ingredients are generally recognized as safe for supplementation.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Engage
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

150 mg
Market median: 250.0mg (562 products) 55 studies (A:0, B:19)
Cranberry extract
150 mg
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
N-Acetyl-L-Cysteine
125 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)

Other Ingredients

Rice Flour Gelatin Calcium Silicate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 1 capsule 2 times per day, preferably with a meal.

Warnings & Precautions

Warning: This product is meant to be consumed by healthy adults 18 years of age or older.

Do not use this product if you are pregnant or nursing. Before using this product consult with your physician if you are using any prescription or over the counter medication or supplements.

Do not take this product if you are at risk or being treated for any pre-existing medical condition included but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney, seizure, or thyroid disorders.

If you have diabetes, difficulty urinating due to an enlarged prostate or if you are taking an MAO inhibitor.

Discontinue use and consult your health care professional if you experience any adverse side effects to this product. Healthcare professional immediately if you experience an usually rapid heartbeat, dizziness, severe headache, or shortness of breath.

Keep out of the reach of children.

Formulation Notes

Preventative care

Additional Information

Made in the USA FDA registered facility GMP Good Manufacturing Practice

Metadata

Product Details

UPC / SKU685867 925491
DSLD Entry Date2020-09-25
Product TypeOther Combinations
FormCapsule
DSLD ID236842
Data Updated2026-04-11
Research

Research Evidence

69
Research Sources
55
Avg Quality
34
Meta Analysis
26
Systematic Review
5
Rct
3
Clinical Trial
1
Openfda Safety
A Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Evaluation of the effect of herbal agents as management of radiodermatitis in breast cancer patients: A systematic review and meta-analysis
Meta Analysis Japan journal of nursing science : JJNS 2024 PubMed DOI
B Efficacy of different interventions for nonalcoholic fatty liver disease: A meta-analysis of lifestyle modifications, silymarin, and medications
Meta Analysis Asia Pacific journal of clinical nutrition 2025 PubMed DOI
B Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
Meta Analysis The Cochrane database of systematic reviews 2007 PubMed
B Pharmacotherapy for trichotillomania
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review
Meta Analysis Medicine 2024 PubMed DOI
B Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury
Meta Analysis BMC complementary medicine and therapies 2025 PubMed DOI
B The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis
Meta Analysis Medicine 2020 PubMed DOI
B Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis
Meta Analysis Annals of hepatology 2024 PubMed DOI
View all evidence for Milk Thistle →
Compare

Similar Products

View all Milk Thistle products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.